Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.19 +0.01 +5.56%
|
OTCQB:IOTCF
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL™ Silver
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
Back to Financial Statements
Consolidated Financial Statements and MD&A for December 31, 2025 and 2024
April 1, 2026
Download Financial Statements
Accompanying MD&A
